Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × High Grade Squamous Intra-epithelial Lesion (HSIL) × pomalidomide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 14 Recurrence 3 Neoplasms, Plasma Cell 2 Renal Insufficiency 1 Paraproteinemias 1 Neoplasms by Histologic Type 1 Neoplasms 1 Hypoxia 1 High Grade Squamous Intra-epithelial Lesion (HSIL) 1 Hematologic Diseases 1 Disease Progression 1 Blood Protein Disorders 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03113942 2022-03-31

SPACE

Kirby Institute

Phase 2 Unknown

High Grade Squamous Intra-epithelial Lesion (HSIL)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡